Ligand-independent and tissue-selective androgen receptor inhibition by pyrvinium. - Wikidata - wikimedia - TriplyDB

Ligand-independent and tissue-selective androgen receptor inhibition by pyrvinium.

Ligand-independent and tissue-selective androgen receptor inhibition by pyrvinium.

http://www.wikidata.org/entity/Q37656304

about

Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancer.Molecular pathways and targets in prostate cancer Recent advances in allosteric androgen receptor inhibitors for the potential treatment of castration-resistant prostate cancer.Drug affinity responsive target stability (DARTS) for small-molecule target identification.Are androgen receptor variants a substitute for the full-length receptor?The novel role of pyrvinium in cancer therapy.Synthesis and evaluation of novel thiazole-based derivatives as selective inhibitors of DNA-binding domain of the androgen receptor.Androgen inhibits key atherosclerotic processes by directly activating ADTRP transcription.Complex HuR function in pancreatic cancer cells.Bypassing Drug Resistance Mechanisms of Prostate Cancer with Small Molecules that Target Androgen Receptor-Chromatin Interactions.

P2860

Q34249190-3D35BA22-38CA-4BA7-AC7A-2604D0C20780 Q34365632-C15D3FFF-C1FC-430E-920D-A904DC6543F7 Q34495028-2EEFCE63-365D-4415-B0BE-7CF424963A54 Q35548750-1BCD69BE-78A9-4051-B644-791531AD00AF Q38350089-D9D76A1C-C4B2-42C1-BDED-387B0997B6EF Q38684406-EE6F383E-7FE0-46CA-9117-5EB981159838 Q38698469-7F3ADA1C-404B-4B8E-B50C-CE10568EB4AC Q38711524-DE244121-C116-4400-B38A-03B2102E97C3 Q49922188-4CA3BA85-E732-451A-85A9-71C14592D78D Q53126460-B19F9BE9-FEB1-494B-A2E6-1B7DC017B120

P2860

Ligand-independent and tissue-selective androgen receptor inhibition by pyrvinium.

http://www.wikidata.org/entity/Q37656304

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Ligand-independent and tissue-selective androgen receptor inhibition by pyrvinium.

@en

Ligand-independent and tissue-selective androgen receptor inhibition by pyrvinium.

@nl

type

label

Ligand-independent and tissue-selective androgen receptor inhibition by pyrvinium.

@en

Ligand-independent and tissue-selective androgen receptor inhibition by pyrvinium.

@nl

prefLabel

Ligand-independent and tissue-selective androgen receptor inhibition by pyrvinium.

@en

Ligand-independent and tissue-selective androgen receptor inhibition by pyrvinium.

@nl

P1433

Q37656304-CC0D73BF-F90D-4ADB-B724-8BB5680AC37F

P1476

Q37656304-5743085E-A165-41F1-901E-00B2F1C4D501

P2093

Q37656304-56C77500-1C9B-4A04-96AB-0C6691D590EB

Q37656304-823C2B4B-FA35-4C00-A458-3FA38E96D71B

Q37656304-C5675BB1-DEEA-4487-85A5-7EC1DEAB695C

Q37656304-EC680C98-E142-4485-A6F0-70702A747613

Q37656304-F2D70EA2-1BFC-4DDB-BBD3-C80EC6893669

Q37656304-F6205015-9AD2-4FE7-95E3-072B09EA558B

P2860

Q37656304-02879A9B-DDDE-4559-9388-505E52B878B9

Q37656304-099B770A-0E84-4DAF-A047-4C2BAB9DD834

Q37656304-1821C372-48AD-493E-9B42-BFC32EE5892F

Q37656304-2B92D67B-6FBD-49AD-8E8E-B4B875365747

Q37656304-2F465228-C602-4D9A-9177-074C0E1472CF

Q37656304-3C8AC81D-D0C8-4FA9-930B-A30AAB366C68

Q37656304-41FD6451-5A7D-4843-BAB6-292C036A3444

Q37656304-4DDB8164-4000-43DC-B2B9-BA3C2DE93AE8

Q37656304-54ACDA48-1AEB-49B4-B93F-2657FBC0BB0B

Q37656304-54E3E6E1-DF17-46AF-8165-60EF90C79EC0

P304

Q37656304-29C83F15-C352-4979-A53E-8F286A6C14ED

P31

Q37656304-9C624C46-316B-4B95-A7AC-0F25B2CE98F1

P356

Q37656304-5238EA31-1BCD-4BDC-89DF-28FC52DBE23D

P433

Q37656304-F065AB43-72DD-40F5-8CCF-6787D2898702

P478

Q37656304-D5434986-E766-4AD8-B201-0BB8AE8935D9

P50

Q37656304-A99A1C94-0D1F-4D2A-9380-A2ADDFF201B0

Q37656304-C75DAF06-E78C-46EA-8132-96A590D9A40F

P577

Q37656304-1105BD2B-0531-401B-9CA1-4032E56A2087

P698

Q37656304-20DB3B71-0804-4B85-8322-F2365D62FD75

P932

Q37656304-06E81787-FDAF-41F3-B743-42760448E90B

P356

P1433

ACS Chemical Biology

P1476

Ligand-independent and tissue-selective androgen receptor inhibition by pyrvinium.

@en

P2093

Dan Nguyen

http://www.w3.org/2001/XMLSchema#string

Emily Chin

http://www.w3.org/2001/XMLSchema#string

Leila Su

http://www.w3.org/2001/XMLSchema#string

Maya Otto-Duessel

http://www.w3.org/2001/XMLSchema#string

Miaoling He

http://www.w3.org/2001/XMLSchema#string

Minyoung Lim

http://www.w3.org/2001/XMLSchema#string

P2860

Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor

Glucocorticoid receptor homodimers and glucocorticoid-mineralocorticoid receptor heterodimers form in the cytoplasm through alternative dimerization interfaces

From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells

A surface on the androgen receptor that allosterically regulates coactivator binding

Cancer statistics, 2013

A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth

Molecular determinants of resistance to antiandrogen therapy

Androgen and glucocorticoid receptor heterodimer formation. A possible mechanism for mutual inhibition of transcriptional activity

Steroid receptor heterodimerization demonstrated in vitro and in vivo

Increased survival with enzalutamide in prostate cancer after chemotherapy

P304

692-702

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/CB400759D

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Tamara Alliston

P577

2014-01-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24354286

http://www.w3.org/2001/XMLSchema#string

P932

3962707

http://www.w3.org/2001/XMLSchema#string